These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2150640)
1. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). Grimm RH; Flack JM; Byington R; Bond G; Brugger S Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640 [TBL] [Abstract][Full Text] [Related]
2. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group. Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828 [TBL] [Abstract][Full Text] [Related]
3. Multicenter study with isradipine and diuretics against atherosclerosis. US MIDAS Research Group. Borhani NO; Brugger SB; Byington RP J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S23-9. PubMed ID: 1695298 [TBL] [Abstract][Full Text] [Related]
4. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group. Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479 [TBL] [Abstract][Full Text] [Related]
5. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data. Applegate WB; Byington RP Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000 [TBL] [Abstract][Full Text] [Related]
6. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587 [TBL] [Abstract][Full Text] [Related]
7. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group. Borhani NO Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295 [TBL] [Abstract][Full Text] [Related]
8. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group. Furberg CD; Byington RP; Borhani NA Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653 [TBL] [Abstract][Full Text] [Related]
9. Interventional clinical trials using noninvasive ultrasound end points: the Multicenter Isradipine/Diuretic Atherosclerosis Study. The MIDAS Research Group. Bond MG; Strickland HL; Wilmoth SK; Safrit A; Phillips R; Szostak L J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S30-3. PubMed ID: 1695299 [TBL] [Abstract][Full Text] [Related]
10. The antiatherosclerotic effect of calcium antagonists in man--what did MIDAS actually show? Multicenter Isradipine Diuretic Atherosclerosis Study. Hansson L; Zanchetti A Blood Press; 1995 May; 4(3):133-6. PubMed ID: 7670645 [TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group. Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910 [TBL] [Abstract][Full Text] [Related]
12. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study. Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723 [TBL] [Abstract][Full Text] [Related]
13. Isradipine in prediabetic hypertensive subjects. Byington RP; Furberg CD; Craven TE; Pahor M; Sowers JR Diabetes Care; 1998 Dec; 21(12):2103-10. PubMed ID: 9839101 [TBL] [Abstract][Full Text] [Related]
14. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation. Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945 [TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens. Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865 [TBL] [Abstract][Full Text] [Related]
16. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Bond MG; Wilmoth SK; Enevold GL; Strickland HL Am J Med; 1989 Apr; 86(4A):33-6. PubMed ID: 2523652 [TBL] [Abstract][Full Text] [Related]
17. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients. Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060 [TBL] [Abstract][Full Text] [Related]
18. How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study. Hansson L Blood Press Suppl; 1996; 4():16-9. PubMed ID: 8973777 [TBL] [Abstract][Full Text] [Related]
19. The place of isradipine in the treatment of hypertension. Man in't Veld AJ Am J Hypertens; 1991 Feb; 4(2 Pt 2):96S-102S. PubMed ID: 1827026 [TBL] [Abstract][Full Text] [Related]
20. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Brogden RN; Sorkin EM Drugs; 1995 Apr; 49(4):618-49. PubMed ID: 7789292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]